Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New-onset Type 2 Diabetes”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Post-approval studies (Phase 4)Looking for participantsNCT06888050
What this trial is testing

Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study

Who this might be right for
New-onset Type 2 Diabetes
Zhejiang Provincial People's Hospital 268
Post-approval studies (Phase 4)Study completedNCT01390480
What this trial is testing

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Medical University of Graz 31
Large-scale testing (Phase 3)Study completedNCT00162240
What this trial is testing

PPAR - Combination With Metformin

Who this might be right for
Diabetes Mellitus
Bristol-Myers Squibb 534
Testing effectiveness (Phase 2)Ended earlyNCT03895437
What this trial is testing

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients

Who this might be right for
Diabetes Mellitus, Type 1
Tolerion, Inc. 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227221
What this trial is testing

Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Second Xiangya Hospital of Central South University 10
Not applicableStudy completedNCT01402388
What this trial is testing

Lifestyle Intervention in Patients With New Onset Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes
The Royal Bournemouth Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00146484
What this trial is testing

Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Children's Hospital of Eastern Ontario 100
Not applicableEnded earlyNCT03731637
What this trial is testing

Establish a New Onset Hyperglycemia and Diabetes Cohort

Who this might be right for
DiabetesType2 DiabetesDiabetes Mellitus
Fred Hutchinson Cancer Center 2,269
Not applicableUnknownNCT04164602
What this trial is testing

The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly

Who this might be right for
Diabetes MellitusDiabetesDiabetes Mellitus, Type 2+5 more
University of Pecs 2,522
Testing effectiveness (Phase 2)Ended earlyNCT04899271
What this trial is testing

Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

Who this might be right for
New-onset Type 1 Diabetes
Dompé Farmaceutici S.p.A 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05743244
What this trial is testing

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 78
Not applicableUnknownNCT04847414
What this trial is testing

Novel Classification of Adult-onset Diabetes and Its Association With Common Microvascular Complications in Upper Egypt

Who this might be right for
Diabetes Mellitus, Type 2
Sohag University 1,000
Large-scale testing (Phase 3)Study completedNCT01645332
What this trial is testing

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

Who this might be right for
Type-2-diabetes MellitusNew Onset
Dexa Medica Group 104
Testing effectiveness (Phase 2)Study completedNCT04774224
What this trial is testing

Baricitinib in New-onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
St Vincent's Institute of Medical Research 91
Post-approval studies (Phase 4)Ended earlyNCT01002339
What this trial is testing

Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation

Who this might be right for
Diabetes Mellitus, Adult-Onset
Armando Torres Ramírez 134
Post-approval studies (Phase 4)Study completedNCT00131846
What this trial is testing

Diuretics In the Management of Essential Hypertension (DIME) Study

Who this might be right for
Hypertension
Kyoto University 1,130
Testing effectiveness (Phase 2)Study completedNCT02814838
What this trial is testing

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
Dompé Farmaceutici S.p.A 76
Post-approval studies (Phase 4)UnknownNCT04535830
What this trial is testing

The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Flash Glucose Monitoring
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Not applicableActive Not RecruitingNCT02488733
What this trial is testing

Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients

Who this might be right for
Type 2 Diabetes Mellitus
Azienda Ospedaliera Santa Maria, Terni, Italy 30
Next Page